Docking compared to 3D-pharmacophores: the scoring function challenge

Ripphausen, P. et al. (in press) Quo vadis, virtual screening? A comprehensive survey of prospective applications. J. Med. Chem, doi:10.1021/jm101020z Markt, P. et al. (2011) Pharmacophore models for virtual screening. In Virtual Screening. Principles, Challenges, and Practical Guidelines (Sotriffer, C., ed.), Wiley-VCH Leach, 2010, Three-dimensional pharmacophore methods in drug discovery, J. Med. Chem., 53, 539, 10.1021/jm900817u Yang, 2010, Pharmacophore modeling and applications in drug discovery: challenges and recent advances, Drug Discov. Today, 15, 444, 10.1016/j.drudis.2010.03.013 Howe, T. et al. (2011) Scenarios and case studies: examples for ligand-based virtual screening. In Virtual Screening. Principles, Challenges, and Practical Guidelines (Sotriffer, C., ed.), Wiley-VCH Baroni, 2007, A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application, J. Chem. Inf. Model., 47, 279, 10.1021/ci600253e Brenk, 2003, Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis, J. Med. Chem., 46, 1133, 10.1021/jm0209937 Ortuso, 2006, GBPM: GRID-based pharmacophore model: concept and application studies to protein–protein recognition, Bioinformatics, 22, 1449, 10.1093/bioinformatics/btl115 Sotriffer, 2002, Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design, Farmaco, 57, 243, 10.1016/S0014-827X(02)01211-9 Wolber, 2005, LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters, J. Chem. Inf. Model., 45, 160, 10.1021/ci049885e Wolber, 2008, Molecule-pharmacophore superpositioning and pattern matching in computational drug design, Drug Discov. Today, 13, 23, 10.1016/j.drudis.2007.09.007 Perola, 2004, Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding, J. Med. Chem., 47, 2499, 10.1021/jm030563w Matter, H. and Sotriffer, C. (2011) Applications and success stories in virtual screening. In Virtual Screening. Principles, Challenges, and Practical Guidelines (Sotriffer, C., ed.), Wiley-VCH Rohrer, 2009, Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data, J. Chem. Inf. Model., 49, 169, 10.1021/ci8002649 Klabunde, 2009, Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening, J. Med. Chem., 52, 2923, 10.1021/jm9001346 Colombo, 2010, Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds, J. Biol. Chem., 285, 8733, 10.1074/jbc.M109.085605 De Luca, 2009, Pharmacophore-based discovery of small-molecule inhibitors of protein–protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75, ChemMedChem, 4, 1311, 10.1002/cmdc.200900070 Kang, 2010, Discovery of novel human phenylethanolamine N-methyltransferase (hPNMT) inhibitors using 3D pharmacophore-based in silico, biophysical screening and enzymatic activity assays, Mol. Cells, 29, 595, 10.1007/s10059-010-0074-3 Tanrikulu, 2009, Structure-based pharmacophore screening for natural-product-derived PPARgamma agonists, Chembiochem, 10, 75, 10.1002/cbic.200800520 Kim, 2010, Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents, Bioorg. Med. Chem., 18, 7092, 10.1016/j.bmc.2010.07.072 Moitessier, 2008, Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go, Br. J. Pharmacol., 153, S7, 10.1038/sj.bjp.0707515 Sousa, 2006, Protein–ligand docking: current status and future challenges, Proteins, 65, 15, 10.1002/prot.21082 Kubinyi, 2006, Success stories of computer-aided design, 377 Cheng, 2009, Comparative assessment of scoring functions on a diverse test set, J. Chem. Inf. Model., 49, 1079, 10.1021/ci9000053 Warren, 2006, A critical assessment of docking programs and scoring functions, J. Med. Chem., 49, 5912, 10.1021/jm050362n Irwin, 2008, Community benchmarks for virtual screening, J. Comput. Aided Mol. Des., 22, 193, 10.1007/s10822-008-9189-4 Sotriffer, 2008, SFCscore: scoring functions for affinity prediction of protein–ligand complexes, Proteins, 73, 395, 10.1002/prot.22058 Charifson, 1999, Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins, J. Med. Chem., 42, 5100, 10.1021/jm990352k Stahl, 2001, Detailed analysis of scoring functions for virtual screening, J. Med. Chem., 44, 1035, 10.1021/jm0003992 Seifert, 2009, Targeted scoring functions for virtual screening, Drug Discov. Today, 14, 562, 10.1016/j.drudis.2009.03.013 Xu, 2009, Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay, Bioorg. Med. Chem. Lett., 19, 3188, 10.1016/j.bmcl.2009.04.113 Park, 2009, Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors, Bioorg. Med. Chem. Lett., 19, 4372, 10.1016/j.bmcl.2009.05.078 Ko, 2009, Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1. Identification of new chelating groups for the active-site ferrous ion, Bioorg. Med. Chem., 17, 7769, 10.1016/j.bmc.2009.09.034 Li, 2009, Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening, J. Med. Chem., 52, 4936, 10.1021/jm801622x Ravindranathan, 2010, Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening, J. Med. Chem., 53, 1662, 10.1021/jm901386e Okamoto, 2009, Identification of death-associated protein kinases inhibitors using structure-based virtual screening, J. Med. Chem., 52, 7323, 10.1021/jm901191q Nagarajan, 2009, IKK[beta] inhibitors identification part I. Homology model assisted structure based virtual screening, Bioorg. Med. Chem., 17, 2759, 10.1016/j.bmc.2009.02.041 Sopkova-de Oliveira Santos, 2010, Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library, J. Chem. Inf. Model., 50, 422, 10.1021/ci900491t Chen, 2009, Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets, Acta Pharmacol. Sin., 30, 1694, 10.1038/aps.2009.159 Totrov, 2008, Flexible ligand docking to multiple receptor conformations: a practical alternative, Curr. Opin. Struct. Biol., 18, 178, 10.1016/j.sbi.2008.01.004